MET and prostate carcinoma: However, MeT did not significantly increase the number of γH2AX foci (Fig. 2G; Supplementary Fig. S1E), a marker of DSBs, suggesting that DNA damage is not a major mechanism underlying its growth-suppressive activity in prostate cancer cells.